Pleasanton


PLEASANTON, California, December 16, 2011 - - The test confidently detects HLA-B*5701 to help decrease risk of abacavir hypersensitivity reaction Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its HLA-B*5701 screening test[1] is now commercially available in Europe.

PLEASANTON, California, October 12, 2011 - CooperVision, Inc.

PLEASANTON, California, August 23, 2011 - - cobas BRAF Mutation Test is used to identify patients with melanoma tumors that harbor a genetic mutation which can be treated with Zelboraf (vemurafenib) Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas BRAF Mutation Test is now commercially available in Europe and in countries that recognize the CE mark.

PLEASANTON, California, July 22, 2011 - - cobas KRAS Mutation Test identifies colorectal cancer patients not likely to respond to anti-EGFR antibody therapies.

PLEASANTON, California, May 23, 2011 - - cobas(R) TaqScreen MPX Test, v2.0(1) provides real-time results for HIV, HCV and HBV Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas(R) TaqScreen MPX Test, version 2.0 for use on the cobas s 201 system is now commercially available in Europe.
Older News
S M T W T F S
28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
Copyright© 2011 The Gaea Times